These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3998934)

  • 1. An unusual pattern of malformation associated with gestational exposure to nasal spray.
    Holm IA; Clarren SK
    J Pediatr; 1985 May; 106(5):860-1. PubMed ID: 3998934
    [No Abstract]   [Full Text] [Related]  

  • 2. Bradycardia, hypotension, and near-syncope associated with Afrin (oxymetazoline) nasal spray.
    Glazener F; Blake K; Gradman M
    N Engl J Med; 1983 Sep; 309(12):731. PubMed ID: 6888446
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse reactions to oxymetazoline.
    Silverman HI
    Lancet; 1984 Aug; 2(8398):347-8. PubMed ID: 6146886
    [No Abstract]   [Full Text] [Related]  

  • 4. Fetal heart rate changes following maternal administration of a nasal decongestant.
    Baxi LV; Gindoff PR; Pregenzer GJ; Parras MK
    Am J Obstet Gynecol; 1985 Dec; 153(7):799-800. PubMed ID: 2416220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

  • 6. CNS reactions to nose drops in small children.
    Söderman P; Sahlberg D; Wiholm BE
    Lancet; 1984 Mar; 1(8376):573. PubMed ID: 6142294
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and toleration of oxymetazoline ophthalmic solution.
    Samson CR; Danzig MR; Sasovetz D; Thompson HS
    Pharmatherapeutica; 1980; 2(6):347-52. PubMed ID: 7433475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of panic disorder precipitated by oxymetazoline withdrawal.
    Saadah HA
    J Clin Psychiatry; 1987 Jul; 48(7):293. PubMed ID: 3597333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branch retinal artery occlusion after excessive use of nasal spray.
    Magargal LE; Sanborn GE; Donoso LA; Gonder JR
    Ann Ophthalmol; 1985 Aug; 17(8):500-1. PubMed ID: 2413795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac arrest after oxymetazoline nasal spray.
    Thrush DN
    J Clin Anesth; 1995 Sep; 7(6):512-4. PubMed ID: 8534470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
    Bielenberg J
    Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
    [No Abstract]   [Full Text] [Related]  

  • 13. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paranoid psychosis induced by oxymetazoline nasal spray.
    Ticoll B; Shugar G
    CMAJ; 1994 Feb; 150(3):375-6. PubMed ID: 8293377
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute coronary syndrome after nasal spray of oxymetazoline.
    Montastruc F; Montastruc G; Taudou MJ; Olivier-Abbal P; Montastruc JL; Bondon-Guitton E
    Chest; 2014 Dec; 146(6):e214-e215. PubMed ID: 25451367
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organelle regeneration: cilia vs microvilli in human nasal mucosa following use of topical decongestant.
    Dudley JP; Beydler SA; Cherry JD
    Otolaryngol Head Neck Surg; 1981; 89(5):800-3. PubMed ID: 6799912
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative preference study between xylometazoline nasal dose spray (Otrivin) and oxymetazoline single-dose pipettes (Nezeril).
    Ekedahl C; Geterud A; Petruson B; Aust R; Odkvist L
    Rhinology; 1983 Sep; 21(3):287-8. PubMed ID: 6195722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.